Efficacy of low dose budesonide inhalation suspension / sodium cromoglicate inhalation solution for mild / moderate persistent asthma in young childre

Not Applicable

• Conditions: bronchial asthma

• Registration Number: JPRN-UMIN000003070
• Lead Sponsor: Mild One research society

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2010-01-21
• Study Completion: 2010-08-01
• Last Update Posted: 17 October 2023

Recruitment & Eligibility

• Status: Complete: follow-up complete
• Sex: All
• Target Recruitment: 40

Inclusion Criteria

Not provided

Exclusion Criteria

1. Patients who have a case listed below within a month a)Severe respiratory infection disease that required hospitalization b)Administration of systemic steroid 2. Patients who have underlying disease that indicate chronic airway symptom exclude asthma

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Daytime and nighttime symptom score at baseline and after 12 weeks of administration (0-3 point scale).

Secondary Outcome Measures

Name	Time	Method
- Score of symptom (based on asthma diary, 0-9 point scale) - Frequency of use inhaled short acting beta2 agonist(SABA) - Level of blood serum cortisol at baseline and end of study - Level of blood serum ECP at baseline and end of study - Unscheduled hospital visits and emergency room visit because of asthma exacerbation - Adverse events